Literatur
- 1
Aronow W S, Kronzon I.
Prevalence and severity
of valvular aortic stenosis determined by Doppler echocardiography
and its association with echocardiographic and electrocardiographic
left ventricular hypertrophy and physical signs of aortic stenosis
in elderly patients.
Am J Cardiol.
1991;
67
776-777
- 2
Aronow W S, Schwartz K S, Koenigsberg M.
Correlation
of serum lipids, calcium, and phosphorus, diabetes mellitus and
history of systemic hypertension with presence or absence of calcified
or thickened aortic cusps or root in elderly patients.
Am
J Cardiol.
1987;
59
998-999
- 3
Chizner M A, Pearle D L, de Leon A C
Jr.
The natural history of aortic stenosis in adults.
Am
Heart J.
1980;
99
419-424
- 4
Davies M J, Treasure T, Parker D J.
Demographic
characteristics of patients undergoing aortic valve replacement
for stenosis: relation to valve morphology.
Heart.
1996;
75
174-178
- 5
Deutscher S, Rockette H E, Krishnaswami V.
Diabetes
and hypercholesterinaemia among patients with calcific aortic stenosis.
J
Chronic Dis.
1984;
37
407-415
- 6
Ghaisas N, Foley B, O’Briain D S, Crean P, Kelleher D, Walsh M.
Role of endothelial adhesion
molecules in the pathogenesis of degenerative aortic valve disease
(Abstract).
Eur Heart J.
1999;
20
598
- 7
Gotoh T, Kuroda T, Yamasawa M. et al .
Correlation
between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography
(the JMS Cardiac Echo and Cohort Study).
Am J Cardiol.
1995;
76
928-932
- 8
Hoagland P M, Cook E F, Flatley M, Walker C, Goldman L.
Case-control analysis
of risk factors for presence of aortic stenosis in adults (age 50 years
or older).
Am J Cardiol.
1985;
55
744-747
- 9
Livanainen A M, Lindroos M, Tilvis R, Heikkila J, Kupari M.
Natural
history of aortic valve stenosis of varying severity in the elderly.
Am
J Cardiol.
1996;
78
97-101
- 10
Kwon H M, Lee B K, Kim D. et al .
Experimental hypercholesterolemia induces
ultrastructural changes in the elastic laminae of rabbit aortic
valve.
Yonsei Med J.
1998;
39
345-54
- 11
Lee Y S, Chou Y Y.
Endothelial alterations
and senile calcific aortic stenosis: an electron microscopic observation.
Proc
Natl Sci Counc Repub China B.
1997;
21
137-143
- 12
Lindroos M, Kupari M, Heikkila J, Tilvis R.
Prevalence of aortic
valve abnormalities in the elderly: an echocardiographic study of
a random population sample.
J Am Coll Cardiol.
1993;
21
1220-1225
- 13
Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkila J, Tilvis R.
Factors associated with
calcific aortic valve degeneration in the elderly.
Eur
Heart J.
1994;
15
865-870
- 14
Maher E R, Pazianas M, Curtis J R.
Calcific
aortic stenosis: A complication of chronic uraemia.
Nephron.
1987;
47
119-122
- 15
Mohler E R
3rd, Adam L P, McClelland P, Graham L, Hathaway D R.
Detection
of osteopontin in calcified human aortic valves.
Arterioscler Thromb
Vasc Biol.
1997;
17
547-552
- 16
Mohler E R, Sheridan M J, Nichols R, Harvey W P, Waller B F.
Development and
progression of aortic valve stenosis: Atherosclerotic risk factors - a causal
relationship?.
Clin Cardiol.
1991;
14
995-999
- 17
Mönckeberg J G.
Der
normale histologische Bau und die Sklerose der Aortenklappen.
Virchow’s
Archiv Pathol Anat.
1904;
176
472-514
- 18
O’Brien K D, Kuusisto J, Reichenbach D D. et al .
Osteopontin is expressed in human aortic
valvular lesions.
Circulation.
1995;
92
2163-2168
- 19
O’Brien K D, Reichenbach D D, Marcovina S M, Kuusisto J, Alpers C E, Otto C M.
Apolipoproteins
B, (a), and E accumulate in the morphologically early lesion of ‘degenerative’ valvular
aortic stenosis.
Arterioscler Thromb Vasc Biol.
1996;
16
523-532
- 20
Olsson M, Dalsgaard C J, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J.
Accumulation of T lymphocytes
and expression of interleukin-2 receptors in nonrheumatic stenotic
aortic valves.
J Am Coll Cardiol.
1994;
23
1162-1170
- 21
Olsson M, Rosenqvist M, Nilsson J.
Expression
of HLA-DR antigen and smooth muscle cell differentiation markers
by valvular fibroblasts in degenerative aortic stenosis.
J
Am Coll Cardiol.
1994;
24
1664-1671
- 22
Olsson M, Thyberg J, Nilsson J.
Presence
of oxidized low density lipoprotein in nonrheumatic stenotic aortic
valves.
Arterioscler Thromb Vasc Biol.
1999;
19
1218-1222
- 23
Otto C M, Kuusisto J, Reichenbach D D, Gown A M, O’Brien K D.
Characterization
of the early lesion of ‘degenerative’ valvular
aortic stenosis. Histological and immunohistochemical studies.
Circulation.
1994;
90
844-853
- 24
Palta S, Pai A M, Gill K S, Pai R G.
New
insights into the progression of aortic stenosis: Implications for
secondary prevention.
Circulation.
2000;
101
2497-2502
- 25
Pomerance A, Darby A J, Hodkinson H M.
Valvular
calcification in the elderly: possible pathogenic factors.
J
Gerontol.
1978;
33
672-675
- 26
Ross J Jr, Braunwald E.
Aortic stenosis.
Circulation.
1968;
38
61-67
- 27
Srivatsa S S, Harrity P J, Maercklein P B. et al .
Increased cellular expression of matrix
proteins that regulate mineralisation is associated with calcification
of native human and procine xenograft bioprosthetic heart valves.
J
Clin Invest.
1997;
99
996-1009
- 28
Stewart B F, Siscovick D, Lind B K. et al .
Clinical factors associated with calcific
aortic valve disease. Cardiovascular Health Study.
J Am
Coll Cardiol.
1997;
29
630-634
- 29
Strickberger S A, Schulman S P, Hutchins G M.
Association
of Paget’s disease of bone with calcific aortic valve disease.
Am
J Med.
1987;
82
953-956
- 30
Traub O, Berk B C.
Laminar
shear stress: Mechanisms by which endothelial cells transduce an
atheroprotective force.
Arterioscler Thromb Vasc Biol.
1998;
18
677-685
- 31
Tunick P A, Freedberg R S, Kronzon I.
Cardiac
findings in the very elderly: Analysis of echocardiography in fifty-eight
nonagenarians.
Gerontology.
1990;
36
206-211
- 32
Vandeplas A, Willems J L, Piessens J, De Geest H.
Frequency of angina pectoris
and coronary artery disease in severe isolated valvular aortic stenosis.
Am
J Cardiol.
1988;
62
117-120
- 33
Zand T, Majno G, Nunnari J J. et al .
Lipid
deposition and intimal stress and strain. A study in rats with aortic
stenosis.
Am J Pathol.
1991;
139
101-113
Korrespondenz
Dr. med. Jens Kaden
II. Medizinische Klinik Universitätsklinikum
Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Telefon: 0621/383-2204
Fax: 0621/383-3821
eMail: jens.kaden@med2.ma.uni-heidelberg.de
